Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

Mesenchymal stem cells inhibit multiple myeloma cells via the Fas/Fas ligand pathway.

Atsuta I, Liu S, Miura Y, Akiyama K, Chen C, An Y, Shi S, Chen FM.

Stem Cell Res Ther. 2013;4(5):111.

PMID:
24025590
[PubMed - in process]
Free PMC Article
2.

Therapeutic effects of intrabone and systemic mesenchymal stem cell cytotherapy on myeloma bone disease and tumor growth.

Li X, Ling W, Khan S, Yaccoby S.

J Bone Miner Res. 2012 Aug;27(8):1635-48. doi: 10.1002/jbmr.1620.

PMID:
22460389
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Umbilical cord blood-derived mesenchymal stem cells inhibit, but adipose tissue-derived mesenchymal stem cells promote, glioblastoma multiforme proliferation.

Akimoto K, Kimura K, Nagano M, Takano S, To'a Salazar G, Yamashita T, Ohneda O.

Stem Cells Dev. 2013 May 1;22(9):1370-86. doi: 10.1089/scd.2012.0486. Epub 2013 Feb 4.

PMID:
23231075
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Low FasL levels promote proliferation of human bone marrow-derived mesenchymal stem cells, higher levels inhibit their differentiation into adipocytes.

Rippo MR, Babini L, Prattichizzo F, Graciotti L, Fulgenzi G, Tomassoni Ardori F, Olivieri F, Borghetti G, Cinti S, Poloni A, Fazioli F, Procopio AD.

Cell Death Dis. 2013 Apr 18;4:e594. doi: 10.1038/cddis.2013.115.

PMID:
23598406
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells.

Ciavarella S, Grisendi G, Dominici M, Tucci M, Brunetti O, Dammacco F, Silvestris F.

Br J Haematol. 2012 Jun;157(5):586-98. doi: 10.1111/j.1365-2141.2012.09082.x. Epub 2012 Mar 16.

PMID:
22420897
[PubMed - indexed for MEDLINE]
6.

Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo.

Xu S, Menu E, De Becker A, Van Camp B, Vanderkerken K, Van Riet I.

Stem Cells. 2012 Feb;30(2):266-79. doi: 10.1002/stem.787.

PMID:
22102554
[PubMed - indexed for MEDLINE]
Free Article
7.

Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization.

Suzuki K, Sun R, Origuchi M, Kanehira M, Takahata T, Itoh J, Umezawa A, Kijima H, Fukuda S, Saijo Y.

Mol Med. 2011;17(7-8):579-87. doi: 10.2119/molmed.2010.00157. Epub 2011 Mar 11.

PMID:
21424106
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Inhibition of TGF-β/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects.

Shangguan L, Ti X, Krause U, Hai B, Zhao Y, Yang Z, Liu F.

Stem Cells. 2012 Dec;30(12):2810-9. doi: 10.1002/stem.1251.

PMID:
23034983
[PubMed - indexed for MEDLINE]
Free Article
9.

[Human umbilical cord mesenchymal stem cells with adenovirus-mediated interleukin 12 gene transduction inhibits the growth of ovarian carcinoma cells both in vitro and in vivo].

Zhao WH, Cheng JX, Shi PF, Huang JY.

Nan Fang Yi Ke Da Xue Xue Bao. 2011 May;31(5):903-7. Chinese.

PMID:
21602155
[PubMed - indexed for MEDLINE]
Free Article
10.

Human and mouse colon cancer utilizes CD95 signaling for local growth and metastatic spread to liver.

Li H, Fan X, Stoicov C, Liu JH, Zubair S, Tsai E, Ste Marie R, Wang TC, Lyle S, Kurt-Jones E, Houghton J.

Gastroenterology. 2009 Sep;137(3):934-44, 944.e1-4. doi: 10.1053/j.gastro.2009.06.004. Epub 2009 Jun 12.

PMID:
19524576
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumors.

Zhang T, Lee YW, Rui YF, Cheng TY, Jiang XH, Li G.

Stem Cell Res Ther. 2013 Jun 13;4(3):70. [Epub ahead of print]

PMID:
23763837
[PubMed - as supplied by publisher]
Free PMC Article
12.

Modulation of Fas-Fas ligand interaction rehabilitates hypoxia-induced apoptosis of mesenchymal stem cells in ischemic myocardium niche.

Ham O, Lee SY, Song BW, Cha MJ, Lee CY, Park JH, Kim IK, Lee J, Seo HH, Seung MJ, Choi E, Jang Y, Hwang KC.

Cell Transplant. 2014 May 12. [Epub ahead of print]

PMID:
24823387
[PubMed - as supplied by publisher]
13.

Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT).

Martin FT, Dwyer RM, Kelly J, Khan S, Murphy JM, Curran C, Miller N, Hennessy E, Dockery P, Barry FP, O'Brien T, Kerin MJ.

Breast Cancer Res Treat. 2010 Nov;124(2):317-26. doi: 10.1007/s10549-010-0734-1. Epub 2010 Jan 20.

PMID:
20087650
[PubMed - indexed for MEDLINE]
14.

Suppression of cholangiocarcinoma cell growth by human umbilical cord mesenchymal stem cells: a possible role of Wnt and Akt signaling.

Liu J, Han G, Liu H, Qin C.

PLoS One. 2013 Apr 30;8(4):e62844. doi: 10.1371/journal.pone.0062844. Print 2013.

PMID:
23646150
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.

Yang B, Wu X, Mao Y, Bao W, Gao L, Zhou P, Xie R, Zhou L, Zhu J.

Neurosurgery. 2009 Sep;65(3):610-24; discussion 624. doi: 10.1227/01.NEU.0000350227.61132.A7.

PMID:
19687708
[PubMed - indexed for MEDLINE]
16.

Mesenchymal stem cells from primary breast cancer tissue promote cancer proliferation and enhance mammosphere formation partially via EGF/EGFR/Akt pathway.

Yan XL, Fu CJ, Chen L, Qin JH, Zeng Q, Yuan HF, Nan X, Chen HX, Zhou JN, Lin YL, Zhang XM, Yu CZ, Yue W, Pei XT.

Breast Cancer Res Treat. 2012 Feb;132(1):153-64. doi: 10.1007/s10549-011-1577-0. Epub 2011 May 17.

PMID:
21584665
[PubMed - indexed for MEDLINE]
17.

Transplantation of mesenchymal cells rejuvenated by the overexpression of telomerase and myocardin promotes revascularization and tissue repair in a murine model of hindlimb ischemia.

Madonna R, Taylor DA, Geng YJ, De Caterina R, Shelat H, Perin EC, Willerson JT.

Circ Res. 2013 Sep 13;113(7):902-14. doi: 10.1161/CIRCRESAHA.113.301690. Epub 2013 Jun 18.

PMID:
23780385
[PubMed - indexed for MEDLINE]
18.

14S,21R-dihydroxy-docosahexaenoic acid treatment enhances mesenchymal stem cell amelioration of renal ischemia/reperfusion injury.

Tian H, Lu Y, Shah SP, Wang Q, Hong S.

Stem Cells Dev. 2012 May 1;21(7):1187-99. doi: 10.1089/scd.2011.0220. Epub 2011 Oct 3.

PMID:
21846180
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Pharmacologic stem cell based intervention as a new approach to osteoporosis treatment in rodents.

Yamaza T, Miura Y, Bi Y, Liu Y, Akiyama K, Sonoyama W, Patel V, Gutkind S, Young M, Gronthos S, Le A, Wang CY, Chen W, Shi S.

PLoS One. 2008 Jul 9;3(7):e2615. doi: 10.1371/journal.pone.0002615.

PMID:
18612428
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Oncostatin m modulates the mesenchymal-epithelial transition of lung adenocarcinoma cells by a mesenchymal stem cell-mediated paracrine effect.

Wang ML, Pan CM, Chiou SH, Chen WH, Chang HY, Lee OK, Hsu HS, Wu CW.

Cancer Res. 2012 Nov 15;72(22):6051-64. doi: 10.1158/0008-5472.CAN-12-1568. Epub 2012 Nov 8.

PMID:
23139208
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk